Click a link below to view the mailing archive as if it had been sent to you.
| 2023-07-31 12:15 | | US continues to be a top destination for pharma jobs in recent months and more... |
| 2023-07-30 00:15 | | Veeva Systems Reveals Results of Field Medical Engagement Impact Study and more... |
| 2023-07-28 12:15 | | Biogen to acquire rare disease drugmaker Reata for $7.3B and more... |
| 2023-07-28 00:15 | | Facing potential $10B trial loss, Teva seeks appeal of recent ruling in kickbacks case and more... |
| 2023-07-27 12:15 | | Pfizer shuffles R&D leadership to prepare for Seagen merger and more... |
| 2023-07-27 00:15 | | Octapharma secures FDA nod for warfarin reversal agent Balfaxar and more... |
| 2023-07-26 12:15 | | GSK Expects Slower Uptake of RSV Vaccine Amid Record Sales for Shingles Shot and more... |
| 2023-07-26 00:15 | | J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival and more... |
| 2023-07-25 12:15 | | Biogen to eliminate 1,000 jobs in further cost cuts and more... |
| 2023-07-25 00:15 | | Rebuffed by MEI Pharma, Infinity scuttles merger and may face bankruptcy and more... |
| 2023-07-24 12:15 | | Gilead drug acquired in $5B buyout fails key blood cancer trial and more... |
| 2023-07-24 00:15 | | New antitrust merger guidelines could have chilling effect on healthcare deals and more... |
| 2023-07-21 12:15 | | J&J flags potential interference between heart pump and TAVR stents in recall and more... |
| 2023-07-21 00:15 | | Pfizer hails phase 2 data as proof that GBS maternal vaccine offers 'meaningful protection' and more... |
| 2023-07-20 12:15 | | Pfizer plant in North Carolina severely damaged by tornado and more... |
| 2023-07-20 00:15 | | Pfizer spies cardiovascular potential in Riparian preclinical licensing agreement and more... |
| 2023-07-19 12:15 | | Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt and more... |
| 2023-07-19 00:15 | | Novartis raises drug sales forecast, plans new stock buybacks and more... |
| 2023-07-18 12:15 | | AAIC: First Clinical Data from an RNAi Therapeutic for Alzheimer’s Continue to Impress and more... |
| 2023-07-18 00:15 | | Novartis buys a preclinical biotech and its RNA drug technology and more... |
| 2023-07-17 12:15 | | Pardes Biosciences changes hands (sort of) in wake of COVID-19 trial fail and more... |
| 2023-07-17 00:15 | | Why new Alzheimer’s drugs are in for a tepid launch and more... |
| 2023-07-14 12:15 | | Roche in Talks to Buy Stomach Drug from Roivant for $7B: Report and more... |
| 2023-07-14 00:15 | | MIT researchers to lead a new center for continuous mRNA manufacturing and more... |
| 2023-07-13 12:15 | | FDA approves Opill, the first OTC birth control pill in the U.S. and more... |
| 2023-07-13 00:15 | | Merck applies more pressure against IRA, asking for decision without trial in fight with US government and more... |
| 2023-07-12 12:15 | | 7 Life Science IPOs in 2023 and more... |
| 2023-07-12 00:15 | | Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech and more... |
| 2023-07-11 12:15 | | Novartis retreats from TIGIT, handing $300M candidate back to BeiGene and more... |
| 2023-07-11 00:15 | | European regulators probe suicide risk to Ozempic, other Novo drug Saxenda and more... |
| 2023-07-07 12:15 | | Following in Biogen's wake, BrainStorm analyzes effect of ALS cell therapy on biomarker and more... |
| 2023-07-07 00:15 | | Leqembi Wins Full FDA Approval as First Anti-Amyloid Antibody for Alzheimer’s and more... |
| 2023-07-06 12:15 | | Bausch + Lomb Buys J&J’s Dry Eye Drops for $106.5M in Expansion of OTC Business and more... |
| 2023-07-06 00:15 | | Gilead, Teva prevail in high-stakes trial over HIV drug pay-for-delay claims and more... |
| 2023-07-05 12:15 | | FTC Scrutiny Chills Medtech M&A Market and more... |
